Korean hospitals start prescribing Hanmi's GLP-1 drug, the first developed in the country, turning the local obesity market into a three-way race.
Recap by typeshit. Full story at KED Global.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
Drugs.com
Researchers in Seoul found 10-year cancer rates rose from 1.8% at normal weight to 2.6% with severe obesity, with belly fat showing the highest rates.
10:16
Froese compares the growth hormone releasing peptide tesamorelin with Lilly's experimental retatrutide and asks how the two might fit together.
Loading…